GGrantIndex
Sort

1,049,261 grants matching t cell

Development of MRI Techniques for Applications in Substance Use Disorders

$2,565,601
Yihong Yang · National Institute On Drug Abuse · ZIA · FY2024 · DA

Chemical Receptor Interactions In Reproduction And Hormonal Toxicity

$2,565,323
Kenneth S Korach · National Institute Of Environmental Health Sciences · ZIA · FY2018 · ES

Exploring the involvement of Na pump inhibitor marinobufagenin in the interactions between age-associated vascular and neurodegenerative processes in cognitive impairment and Alzheimer's disease

$2,565,266
Olga V Fedorova · National Institute On Aging · ZIA · FY2020 · AG

Determinants of TB control, relapse and reinfection

$2,565,026
Sabine Ehrt · Weill Medical Coll Of Cornell Univ · U19 · FY2023 · AI

THE UW/FHCRC PROGRAM OF EXCELLENCE IN GENE THERAPY

$2,565,002
University Of Washington · U01 · FY2000 · HL

A Human Stem Cell-Derived Neuromuscular Junction Model for Amyotrophic Lateral Sclerosis

$2,565,000
Brian Jason Wainger · Massachusetts General Hospital · DP2 · FY2017 · NS

A versatile platform for reconstructing the spatial organization of intracellular signaling during cell-division

$2,565,000
Radhika Subramanian · Massachusetts General Hospital · DP2 · FY2017 · GM

Defining Melanoma Therapeutic Avenues by Integrative Functional Genomics

$2,565,000
Levi Alexander Garraway · Dana-Farber Cancer Inst · DP2 · FY2007 · OD

Defining and Exploiting a Genetic Template for an HIV Vaccine

$2,565,000
Daniel Lingwood · Massachusetts General Hospital · DP2 · FY2016 · DA

Molecular Level Analysis of Macromolecule-Surface Interactions in Bacterial Adhesion

$2,564,993
Bruce E Logan · Pennsylvania State Univ University Park · · FY2000 · MPS

SPORE IN PROSTATE CANCER

$2,564,919
University Of Michigan At Ann Arbor · P50 · FY2000 · CA

Structure-Function Studies Of DNA Replication Fidelity

$2,564,742
Thomas A Kunkel · National Institute Of Environmental Health Sciences · ZIA · FY2021 · ES

Finding Genes for Cancer Susceptibility and Growth Regulation

$2,564,662
Elaine Ostrander · National Human Genome Research Institute · ZIA · FY2010 · HG

Clinical Studies of Vaccines for Pandemic Influenza

$2,564,575
Kanta Subbarao · National Institute Of Allergy And Infectious Diseases · ZIA · FY2014 · AI

Molecular Targeting of Developmental Cancers in Children

$2,564,487
Richard J O'Reilly · Sloan-Kettering Inst Can Research · P01 · FY2007 · CA

Local Neuronal Drive and Neuromodulatory Control of Activity in the Pial Neurovascular Circuit

$2,564,400
Anna Devor · Boston University (Charles River Campus) · U19 · FY2025 · NS

Translational Immunology Research and Accelerated [vaccine] Development (TRIAD)

$2,564,398
Anne Searls De Groot · University Of Rhode Island · U19 · FY2010 · AI

Spatiotemporal Tumor Analytics for Guiding Sequential Targeted-Inhibitor: Immunotherapy Combinations (ST-Analytics)

$2,564,339
James R. Heath · Institute For Systems Biology · U54 · FY2025 · CA

Improving Prediction of Drug Action

$2,564,195
Dan M Roden · Vanderbilt University Medical Center · P50 · FY2016 · GM

Mechanism Of Action And Functions Of The Gli-related Proteins Glis 1-3

$2,564,145
Anton M Jetten · National Institute Of Environmental Health Sciences · ZIA · FY2021 · ES

Mechanisms and Therapy of Chronic Graft-vs.-Host Disease

$2,563,941
Corey S Cutler · Dana-Farber Cancer Inst · P01 · FY2025 · HL

Expanding Excellence in Developmental Biology in Oklahoma

$2,563,648
Linda F. Thompson · Oklahoma Medical Research Foundation · P20 · FY2020 · GM

Expanding Excellence in Developmental Biology in Oklahoma

$2,563,648
Linda F. Thompson · Oklahoma Medical Research Foundation · P20 · FY2022 · GM

Expanding Excellence in Developmental Biology in Oklahoma

$2,563,648
Linda F. Thompson · Oklahoma Medical Research Foundation · P20 · FY2019 · GM

Expanding Excellence in Developmental Biology in Oklahoma

$2,563,648
Linda F. Thompson · Oklahoma Medical Research Foundation · P20 · FY2021 · GM